Abiopharma

🔍 Kirk Sigurd (Director)

Company: Assertio Holdings, Inc. (ASRT)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 4,851 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 12,017.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2026 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy.
• F2: On December 26, 2025, the Issuer effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.